#######################
# Document Properties #
#######################

SET DOCUMENT Licenses    = "MIT License"
SET DOCUMENT ContactInfo = "farah.humayun@scai-extern.fraunhofer.de"

SET DOCUMENT Name        = "heme_29603246.bel"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Farah Humayun"
SET DOCUMENT Description = "Heme BEL model is a disease model based on Biological Expression Language (BEL) containing the core mechanisms of heme as modulator in Hemolytic diseases such as sickle-cell anemia, beta-thalassemia, malaria and autoimmune hemolytic anemia."

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns"
DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns"
DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns"
# DEFINE NAMESPACE FB           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/80171ae62cf43aa1fc8a6c326b94537ab342458c/external/fb-names.belns"
DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/export/hbp-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns"
DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns"
DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns"
DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns"
DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns"
DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns"
DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns"

# Namespaces hosted on https://arty.scai.fraunhofer.de/artifactory/bel/namespace
# ------------------------------------------------------------------------------
DEFINE NAMESPACE CTO            AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns"
DEFINE NAMESPACE DO             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns"
DEFINE NAMESPACE HP             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns"
DEFINE NAMESPACE SCOMP          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns"
DEFINE NAMESPACE SFAM           AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

DEFINE NAMESPACE HM        AS PATTERN ".*"


###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------

DEFINE ANNOTATION Species       AS PATTERN ".*"
DEFINE ANNOTATION TimePoint     AS PATTERN ".*"
DEFINE ANNOTATION Concentration     AS PATTERN ".*"


# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############

SET Citation = {"PubMed", "Transfusion. 2018 Jul;58(7):1631-1639. doi: 10.1111/trf.14601. Epub 2018 Mar 30.", "29603246"} 

SET TextLocation = "Introduction"

SET Evidence = "Increased circulating cell-free Hb, heme, and iron and
decreased haptoglobin concentrations have been associated
with morbidity and mortality in both animal models
and patients.4,5"

p(HGNC:HP) neg a(MESH:Morbidity)
p(HGNC:HP) neg a(MESH:Mortality)

SET Evidence = "There are in vitro and animal model data
linking increased free Hb, heme, and iron to inflammation,
6 infection,7 platelet (PLT) activation,8,9 vasculopathy,
10 and thrombosis."

p(HGNC:HBB) pos path(MESH:Inflammation)
a(CHEBI:heme) pos path(MESH:Inflammation)
a(CHEBI:"iron(2+)") pos path(MESH:Inflammation)

p(HGNC:HBB) pos bp(MESH:"Platelet Activation")
a(CHEBI:heme) pos bp(MESH:"Platelet Activation")
a(CHEBI:"iron(2+)") pos bp(MESH:"Platelet Activation")

p(HGNC:HBB) pos path(MESH:"Vascular Diseases")
a(CHEBI:heme) pos path(MESH:"Vascular Diseases")
a(CHEBI:"iron(2+)") pos path(MESH:"Vascular Diseases")

p(HGNC:HBB) pos path(MESH:Thrombosis)
a(CHEBI:heme) pos path(MESH:Thrombosis)
a(CHEBI:"iron(2+)") pos path(MESH:Thrombosis)

SET Evidence = "Furthermore, experiments of nature that lead to increased
levels of chronic hemolysis, such as sickle cell anemia and
paroxysmal nocturnal hemoglobinuria, provide evidence
that low levels of hemolysis may be harmful, and contribute
to inflammation, thrombosis, vasculopathy, and
impaired host defenses against infection.1,11"

SET MeSHDisease = "Anemia, Sickle Cell"|"Hemoglobinuria, Paroxysmal"
path(MESH:Hemolysis) pos path(MESH:Inflammation)
path(MESH:Hemolysis) pos path(MESH:"Vascular Diseases")
path(MESH:Hemolysis) pos path(MESH:Thrombosis)

SET TextLocation = "Results"

SET Evidence = "However, patients who died had significantly higher
plasma cell-free Hb and lower haptoglobin concentrations
at all time points, preoperatively and immediately postoperatively
and 6 and 12 hours postoperatively (Fig. 1 shows the
12-hr postoperative data)."

p(HGNC:HBB) neg p(HGNC:HP)

SET Evidence = "The postoperative infection rate
was significantly higher in children receiving the oldest
blood (third tertile, 25-38 days) compared to those receiving
the freshest RBCs (first tertile, 7-15 days) (34% vs. 7%;
p50.004)."

SET TimePoint = "25-38 days"|"Postoperative"
a(HM:"stored erythrocytes") pos path(MESH:Infection)

SET Evidence = "Adult normal
levels of preoperative haptoglobin were associated with a
substantially, but not significantly lower rate of infection
than lower levels (Table 1, second row)."

p(HGNC:HP) neg path(MESH:Infection)

SET Evidence = "The median (and meanâ€”data not shown) free Hb levels
preoperatively and at all postoperative time points (immediately
and 6 and 12 hr postoperatively) were higher
(p50.057) in those who later developed a proven thrombosis
(Fig. 3 displays the 12-hr data)."

p(HGNC:HBB) pos path(MESH:Thrombosis)

SET Evidence  = "Adult normal
levels of preoperative haptoglobin were associated with a
substantially and significantly lower incidence of thrombosis
than lower levels of haptoglobin (Table 1; row 3)."

SET TimePoint = "Preoperative"
p(HGNC:HP) neg path(MESH:Thrombosis)

SET Evidence = "Preoperative adult normal haptoglobin levels, compared
with lower preoperative haptoglobin levels, were
associated with significantly lower Day 1 peak blood lactate
levels and higher nadir mean arterial pressures on
day one (Figs. S1 and S2, available as supporting information
in the online version of this paper) as well as on the
first and second days postoperatively (data not shown)."

SET TimePoint = "Preoperative" 
SET MeSHAnatomy = "Blood"
p(HGNC:HP) pos a(CHEBI:lactate)
p(HGNC:HP) neg path(HP:"Elevated mean arterial pressure")

SET TextLocation = "Discussion"

SET Evidence = "Our findings in the complex setting of critically ill pediatric
cardiac surgery patients demonstrate that higher levels
of free Hb and lower levels of haptoglobin are associated
with serious postoperative clinical complications (infection,
thrombosis, death), immunomodulation, and
inflammation."

p(HGNC:HBB) pos path(MESH:Thrombosis)
p(HGNC:HBB) pos bp(MESH:Immunomodulation)
p(HGNC:HBB) pos path(MESH:Inflammation)

SET Evidence = "Lower haptoglobin
levels are associated with poor outcomes, immunomodulation,
and unfavorable changes in physiologic
measures.12,13,26,27"

p(HGNC:HP) neg bp(MESH:Immunomodulation)

SET Evidence = "Children undergoing open heart surgery experience a
progressively increasing risk of postoperative infection and
thrombosis, increasing need for mechanical ventilation and
inotropes, increasing Day 1 through Day 2 peak blood lactate,
and decreased nadir mean arterial pressure as the levels
of free Hb increase and the levels of haptoglobin
decrease."

SET TimePoint = "Postoperative"
p(HGNC:HBB) neg p(HGNC:HP)
p(HGNC:HBB) pos path(MESH:Thrombosis)
SET MeSHAnatomy = "Blood"
p(HGNC:HBB) pos a(CHEBI:lactate)
p(HGNC:HBB) neg path(HP:"Elevated mean arterial pressure")

UNSET TextLocation
###########
